RAD-150 TLB-150 Research Overview
RAD-150, also known as TLB-150 or TLB-150 Benzoate, is a selective androgen receptor modulator research compound commonly discussed as a modified analogue of RAD-140 Testolone. In the SARMs research market, RAD-150 is often described as the benzoate ester form of RAD-140, which is why searches for RAD-150, RAD150, TLB-150, TLB-150 Benzoate, RAD-140 ester and RAD-150 vs RAD-140 often appear together.
RAD-150 sits within SARM research because it is discussed in relation to androgen receptor signalling, receptor binding models, anabolic marker research, tissue-selective pathway studies and analytical testing. Unlike peptide compounds, SARMs are small molecules, not amino-acid peptide chains. This makes RAD-150 different from peptide research compounds such as BPC-157, GHK-Cu, Ipamorelin or IGF-1 LR3.
One important point is that RAD-150 has far less published research available than RAD-140. Much of the online discussion around RAD-150 is based on its structural relationship to RAD-140 rather than a large body of direct RAD-150 studies. PubChem lists TLB 150 Benzoate under CID 68547459 with the molecular formula C27H20ClN5O3, while published RAD-140 research describes RAD-140 as a selective androgen receptor modulator studied for tissue-selective androgen receptor activity.
This article explains RAD-150 from a research-only perspective, including what it is, how it relates to RAD-140, how androgen receptor signalling is studied, and why COA support, identity testing and analytical documentation matter for newer SARMs research compounds.
What is RAD-150
RAD-150 is a non-peptide SARM research compound commonly linked with the names TLB-150, TLB-150 Benzoate and RAD-140 Benzoate. It is usually described as an esterified version of RAD-140 Testolone, with the benzoate modification being the reason it is often compared directly with RAD-140.
SARMs stands for selective androgen receptor modulators. These compounds are studied because they interact with the androgen receptor, also written as AR. The research focus is not simply whether a compound binds to the androgen receptor, but how that receptor interaction affects downstream gene transcription markers, tissue-selective signalling and anabolic-to-androgenic marker patterns.
RAD-150 is best understood as part of the RAD-140 research family, but it should not be treated as identical to RAD-140. A structural modification can change molecular weight, analytical profile, solubility behaviour, stability, and how a compound is interpreted in research models. For RAD-150, many online claims focus on extended activity or altered exposure, but direct published pharmacology data is limited compared with RAD-140.
This is why BioPlex Peptides should present RAD-150 carefully. It can be described as a SARM research compound structurally related to RAD-140, but it should not be promoted using unsupported personal-use claims or performance wording.
RAD-150 is not a peptide. It is not a growth hormone secretagogue. It is not a GLP-1 receptor agonist. It belongs to the selective androgen receptor modulator research category and should be explained through androgen receptor biology, SARM selectivity, molecular structure and analytical testing.
How RAD-150 works in research
RAD-150 is discussed in research through the androgen receptor pathway. The androgen receptor is a nuclear receptor involved in gene expression regulation after ligand binding. When an androgen receptor ligand binds to the receptor, the receptor can undergo structural changes, move through signalling steps and interact with DNA-associated regulatory systems.
Published RAD-140 research explains that androgen receptor activation involves coordinated events including receptor binding, receptor topology change, dissociation of heat shock proteins, receptor dimerisation, phosphorylation, nuclear translocation, co-regulator interaction and modulation of RNA synthesis from androgen-regulated genes.
RAD-150 is usually discussed by comparison with this RAD-140 androgen receptor research model. Because RAD-150 is linked to RAD-140 structurally, the main research interest is how the modified compound may fit into androgen receptor-mediated signalling models.
In research discussions, RAD-150 may be connected with:
androgen receptor signalling
SARM selectivity research
AR ligand binding models
gene transcription marker studies
anabolic marker research
androgenic marker comparison
tissue-selective pathway models
molecular identity testing
HPLC purity analysis
LC-MS confirmation
The key wording is “research model.” RAD-150 should not be described through dose, cycle, transformation or personal-use language. A responsible article should focus on receptor pathways, molecular classification and analytical review.
What researchers study RAD-150 for
RAD-150 is studied and discussed mainly because of its relationship to RAD-140 Testolone. RAD-140 is one of the best-known non-steroidal SARMs and has published preclinical research describing selective androgen receptor modulation. RAD-150 is positioned in the research compound market as a modified analogue, which creates interest around comparison models.
One research focus is androgen receptor binding. SARMs are studied because they can interact with the androgen receptor in ways that differ from traditional steroidal androgen compounds. Researchers may examine receptor binding strength, receptor activation patterns, co-regulator recruitment, tissue marker selectivity and gene expression changes.
Another research focus is tissue-selective signalling. SARM research often looks at whether a compound can produce different marker profiles across different tissue models. RAD-140 research was developed around the idea that androgen receptor ligands may show tissue-selective pharmacology because receptor signalling depends on receptor expression, co-regulator patterns and cell-specific gene regulation.
RAD-150 is also discussed in relation to structural modification. Because it is commonly described as TLB-150 Benzoate or RAD-140 Benzoate, researchers and analytical reviewers may focus on how esterification changes molecular profile and compound behaviour. That makes identity testing especially important.
A third area is analytical testing. Newer SARMs research compounds can be mislabelled or confused with similar compounds. RAD-150, RAD-140 and related research compounds should be reviewed with appropriate analytical methods such as HPLC purity analysis, LC-MS identity confirmation, batch documentation and COA review.
For BioPlex Peptides, RAD-150 should be positioned as a technical SARM research compound, not a lifestyle product. The strongest content angle is androgen receptor signalling, RAD-140 comparison, SARM selectivity, molecular identity and quality documentation.
RAD-150 vs RAD-140 Testolone
RAD-150 and RAD-140 are closely connected in search results, but they should not be treated as the same compound.
RAD-140 Testolone is the better documented compound. Published research describes RAD-140 as a selective androgen receptor modulator with preclinical characterisation. RAD-150 is commonly described as a benzoate ester analogue of RAD-140, but direct published data for RAD-150 itself is much more limited.
The simplest comparison is this:
RAD-140 Testolone is the parent SARM research compound.
RAD-150 TLB-150 is commonly discussed as a modified benzoate ester analogue of RAD-140.
RAD-140 has more direct published research.
RAD-150 is searched heavily because of its structural relationship to RAD-140.
This comparison is useful for customers because many websites describe RAD-150 as though it has the same depth of research as RAD-140. A more careful research explanation should separate known published RAD-140 evidence from the weaker direct evidence base around RAD-150.
The search phrase RAD-150 vs RAD-140 is valuable because it helps explain why customers should understand the difference before choosing a research compound. It also gives BioPlex a chance to stand out by being clearer and more scientific than websites using exaggerated claims.
RAD-150 and androgen receptor signalling
The androgen receptor is the central research pathway for RAD-150. SARMs are designed and studied around selective androgen receptor modulation, meaning the compound interacts with androgen receptor systems in a way that may produce different marker patterns depending on model type and receptor environment.
In basic research terms, androgen receptor signalling involves ligand binding, receptor activation, movement into the nucleus, co-regulator interaction and gene transcription changes. This can influence marker panels connected with muscle cell models, bone marker systems, endocrine feedback studies and tissue-selective research.
RAD-150 is usually discussed under this same SARM framework because of its relationship to RAD-140. The key research terms linked with this section include RAD-150 SARM, selective androgen receptor modulator, androgen receptor signalling, AR binding research, anabolic marker research, tissue-selective SARM and RAD-140 ester.
The stronger BioPlex approach is to explain the receptor pathway clearly without making claims about outcomes. That makes the article useful for education while staying suitable for a research-only supplier.
RAD-150 and SARM selectivity
SARM selectivity is one of the most important ideas in this category. The word “selective” does not mean simple or risk-free. It refers to research interest in how androgen receptor ligands may create different marker patterns across different tissue systems.
RAD-140 research discusses the possibility that tissue-selective activity may be influenced by androgen receptor expression, co-regulator patterns and gene-specific receptor regulation.
RAD-150 is discussed by comparison with this SARM research framework. Researchers may be interested in whether a modified analogue changes receptor interaction, assay behaviour, analytical stability or marker response compared with RAD-140.
For a live BioPlex article, the safe wording is SARM selectivity research, tissue marker analysis, androgen receptor pathway studies and receptor-mediated signalling. Avoid wording that sounds like a result, promise or personal-use instruction.
RAD-150 and molecular structure
RAD-150 is often searched alongside TLB-150 Benzoate because the benzoate wording is part of how the compound is commonly identified. PubChem lists TLB 150 Benzoate with molecular formula C27H20ClN5O3 and the synonym RAD150.
The molecular structure matters because SARMs are small molecules, not peptides. A peptide is built from amino acids in a chain. RAD-150 is a synthetic non-peptide research compound.
This difference is important for customers who may see SARMs and peptides listed on the same website. They are not the same class of compound. Peptides such as Ipamorelin or BPC-157 are studied through peptide-specific receptor or pathway systems. SARMs such as RAD-150, RAD-140, Ostarine and AC-262 are studied through androgen receptor pathway models.
For RAD-150, the benzoate modification also makes analytical testing important. A supplier should not rely only on a product name. Testing should help confirm identity, purity and batch documentation where available.
RAD-150 and analytical testing
Analytical testing is one of the strongest trust signals for RAD-150 because newer or less-documented SARMs can be misrepresented in the wider research compound market.
Testing may include HPLC purity analysis, LC-MS identity confirmation, molecular mass review, impurity profiling and COA documentation. These methods help connect the product label to the actual material supplied.
For RAD-150, testing is especially important because customers may search for:
RAD-150 with COA
RAD-150 SARM UK
TLB-150 Benzoate COA
RAD-150 purity
RAD-150 testing
SARM testing UK
SARMs with COA
RAD-150 research compound
A COA can support transparency, but it should be understood correctly. A COA may show batch information, test method details, purity data and identity information depending on the testing process. It should not be used as vague marketing without context.
BioPlex Peptides can stand out by explaining testing honestly. For research compounds, identity and purity review matter because similar compound names can create confusion, especially when a compound is structurally related to another SARM.
RAD-150 and storage considerations
RAD-150 is not a peptide, but storage and handling still matter for research compounds. Small-molecule SARMs should be protected from poor storage conditions, contamination risk, moisture, heat exposure and unclear batch handling.
A responsible research compound supplier should focus on product organisation, batch control, documentation, careful storage and clean dispatch processes.
For BioPlex Peptides, the trust message should stay consistent across SARMs and peptides: product quality is shaped by sourcing, documentation, analytical testing, storage standards, stock rotation and customer support.
RAD-150 is a technical research compound, so it should not be treated as a simple trend product. Clear storage, product labelling, batch handling and COA support all help customers make more informed decisions.
RAD-150 compared with other SARMs
RAD-150 is usually compared with RAD-140 first, but it may also appear alongside other SARMs such as Ostarine MK-2866, LGD-4033 Ligandrol, AC-262 Accadrine and S-4 Andarine.
Each SARM has a different structure and research profile.
RAD-150 is discussed as a modified RAD-140-related compound.
RAD-140 Testolone is a better documented selective androgen receptor modulator.
Ostarine MK-2866 is one of the most widely recognised SARMs in research and anti-doping discussions.
LGD-4033 Ligandrol is another well-known SARM research compound linked with androgen receptor pathway models.
AC-262 Accadrine is often discussed as a newer SARM research compound with partial agonist activity language in research discussions.
These comparisons help customers understand that SARMs are not all the same. The category is connected by androgen receptor modulation, but each compound has its own structure, research history, analytical profile and terminology.
Why RAD-150 should stay research-only
RAD-150 is heavily discussed online, but many search results use personal-use wording, before-and-after language, performance claims or cycle-style content. That is not suitable for a responsible research compound supplier.
BioPlex Peptides should keep RAD-150 content focused on:
SARM research
androgen receptor signalling
RAD-150 vs RAD-140 comparison
TLB-150 Benzoate structure
AR binding models
tissue-selective marker research
analytical testing
COA review
SARM purity
research compound documentation
This makes the article more professional and more trustworthy.
A research-only page should explain what RAD-150 is, how it is classified, how it relates to RAD-140 and why testing matters. It should not advise use, describe cycles, give personal-use guidance or make body-outcome claims.
Conclusion
RAD-150, also known as TLB-150 or TLB-150 Benzoate, is a selective androgen receptor modulator research compound commonly discussed as a modified analogue of RAD-140 Testolone. It is usually searched alongside terms such as RAD-150 SARM, RAD150, TLB-150 Benzoate, RAD-140 ester, RAD-150 vs RAD-140 and SARMs with COA.
The most important point is that RAD-150 should be explained carefully. RAD-140 has a stronger published research base, while RAD-150 is mainly discussed through its structural relationship to RAD-140. This makes analytical testing, identity review, COA support and clear product education especially important.
RAD-150 belongs to SARM research, not peptide research. It should be studied through androgen receptor signalling, SARM selectivity, AR binding models, tissue-selective marker research, molecular structure and analytical documentation.
For BioPlex Peptides, RAD-150 is best presented as a technical research compound with clear focus on research-only supply, testing transparency, COA support, product documentation and responsible scientific wording.
RAD-150 Research Compound
View RAD-150 Research Compound at BioPlex Peptides ⟶
RAD-140 Testolone Research Compound
View RAD-140 Testolone Research Compound at BioPlex Peptides ⟶
SARMs Research Compounds
View BioPlex Peptides SARMs research compounds ⟶
All discussion is presented strictly for educational and scientific research purposes only, supporting informed study, data interpretation, and responsible laboratory investigation.
